Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional Results available

Radiation Therapy With Protons or Photons in Treating Patients With Liver Cancer

ClinicalTrials.gov ID: NCT03186898

Public ClinicalTrials.gov record NCT03186898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 3, 2026, 11:21 PM EST

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This phase III trial studies how well radiation therapy with protons works compared with photons in treating patients with liver cancer. Radiation therapy, such as photon therapy, uses high energy x-rays to send the radiation inside the body to the tumor while proton therapy uses a beam of proton particles. Proton therapy can stop shortly after penetrating through the tumor and may cause less damage to the surrounding healthy organs and result in better survival in patients with liver cancer.

Study identification

NCT ID
NCT03186898
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
NRG Oncology
Other
Enrollment
116 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 26, 2018 (Actual)
Primary completion
Jan 20, 2026 (Actual)
Completion
Jan 20, 2031 (Estimated)
Last update posted
Nov 3, 2026

2018 – 2031

United States locations

U.S. sites
27
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
Emory Proton Therapy Center Atlanta Georgia 30308 —
Emory University Hospital Midtown Atlanta Georgia 30308 —
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322 —
Emory Saint Joseph's Hospital Atlanta Georgia 30342 —
Northwestern Medicine Cancer Center Warrenville Warrenville Illinois 60555 —
Maryland Proton Treatment Center Baltimore Maryland 21201 —
University of Maryland/Greenebaum Cancer Center Baltimore Maryland 21201 —
Massachusetts General Hospital Cancer Center Boston Massachusetts 02114 —
Corewell Health Dearborn Hospital Dearborn Michigan 48124 —
Corewell Health William Beaumont University Hospital Royal Oak Michigan 48073 —
Corewell Health Beaumont Troy Hospital Troy Michigan 48085 —
Washington University School of Medicine St Louis Missouri 63110 —
Memorial Sloan Kettering Basking Ridge Basking Ridge New Jersey 07920 —
Memorial Sloan Kettering Monmouth Middletown New Jersey 07748 —
Memorial Sloan Kettering Bergen Montvale New Jersey 07645 —
Memorial Sloan Kettering Commack Commack New York 11725 —
Memorial Sloan Kettering Westchester East White Plains New York 10604 —
New York Proton Center New York New York 10035 —
Memorial Sloan Kettering Cancer Center New York New York 10065 —
Memorial Sloan Kettering Nassau Uniondale New York 11553 —
University of Cincinnati Cancer Center-UC Medical Center Cincinnati Ohio 45219 —
Case Western Reserve University Cleveland Ohio 44106 —
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 —
University of Cincinnati Cancer Center-West Chester West Chester Ohio 45069 —
UT MD Anderson Cancer Center Houston Texas 77030 —
Fred Hutchinson Cancer Center Seattle Washington 98109 —
University of Washington Medical Center - Montlake Seattle Washington 98195 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03186898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2026 · Synced Nov 3, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT03186898 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →